skip to Main Content
Área de utilizador

INFO COVID-19

COVID-19 e Doença Cardiovascular

Informação atualizada diariamente, elaborada pelo Prof. Rogério Teixeira e Prof. Mário Santos

COVID-19 e Doença Cardiovascular
Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening

COVID-19 e Doença Cardiovascular
Transition of May Measurement Month to an online hypertension awareness campaign in Korea during the COVID-19 pandemic

COVID-19 e Doença Cardiovascular
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance

COVID-19 e Doença Cardiovascular
Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric cardiovascular magnetic resonance imaging

COVID-19 e Doença Cardiovascular
All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study

COVID-19 e Doença Cardiovascular
The different types of COVID-19 vaccines

COVID-19 e Doença Cardiovascular
Covid19 Vaccines

COVID-19 e Doença Cardiovascular
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis

COVID-19 e Doença Cardiovascular
From EACVI recommendations to the real-world experience: safety of performing echocardiography in the pandemic era

COVID-19 e Doença Cardiovascular
Cardiac function during COVID-19 intensive care unit hospitalisation – deformation analysis and outcomes

COVID-19 e Doença Cardiovascular
Cardiac care of Non-COVID-19 patients during the SARS-CoV-2 pandemic: The pivotal role of CCTA

COVID-19 e Doença Cardiovascular
Subclinical coronary artery disease in COVID-19 patients

COVID-19 e Doença Cardiovascular
The evaluation of myocardial performance index in patients with COVID-19: An echocardiographic follow-up study

COVID-19 e Doença Cardiovascular
Reduction in new cardiac electronic device implantations in Catalonia during COVID-19

COVID-19 e Doença Cardiovascular
Myocarditis in COVID-19 presenting with cardiogenic shock: a case series

COVID-19 e Doença Cardiovascular
Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

COVID-19 e Doença Cardiovascular
Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19

COVID-19 e Doença Cardiovascular
Evolution of cardiac function in COVID 19 patients in the intensive care unit: insights from machine learning

COVID-19 e Doença Cardiovascular
Prognostic utility of quantitative offline 2D-echocardiography in hospitalized patients with COVID-19

COVID-19 e Doença Cardiovascular
Left ventricle longitudinal strain alterations in asymptomatic or mildly symptomatic pediatric patients with recent SARS-CoV-2 infection

Apoio incondicional Novartis

Back To Top
Quero ser Sócio